Insight into the molecular mechanism about lowered dihydrofolate binding affinity to dihydrofolate reductase-like 1 (DHFRL1)

Human dihydrofolate reductase-like 1 (DHFRL1) has been identified as a second human dihydrofolate reductase (DHFR) enzyme. Although DHFRL1 have high sequence homology with human DHFR, dihydrofolate (DHF) exhibits a lowered binding affinity to DHFRL1 and the corresponding molecular mechanism is still unknown. To address this question, we studied the binding of DHF to DHFRL1 and DHFR by using molecular dynamics simulation. Moreover, to investigate the role the 24th residue of DHFR/DHFRL1 plays in DHF binding, R24W DHFRL1 mutant was also studied. The van der Waals interaction are more crucial for the total DHF binding energies, while the difference between the DHF binding energies of human DHFR and DHFRL1 can be attributed to the electrostatic interaction and the polar desolvation free energy. More specifically, lower DHF affinity to DHFRL1 can be mainly attributed to the reduction of net electrostatic interactions of residues Arg32 and Gln35 of DHFRL1 with DHF as being affected by Arg24. The side chain of Arg24 in DHFRL1 can extend deeply into the binding sites of DHF and NADPH, and disturb the DHF binding by steric effect, which rarely happens in human DHFR and R24W DHFRL1 mutant. Additionally, the conformation of loop I in DHFRL1 was also studied in this work. Interestingly, the loop conformation resemble to normal closed state of Escherichia coli DHFR other than the closed state of human DHFR. We hope this work will be useful to understand the general characteristics of DHFRL1.

[1]  Lirong Chen,et al.  Mapping the Binding Site of a Large Set of Quinazoline Type EGF-R Inhibitors Using Molecular Field Analyses and Molecular Docking Studies. , 2003 .

[2]  J. Kublin,et al.  Sustained clinical efficacy of sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Malawi after 10 years as first line treatment: five year prospective study , 2004, BMJ : British Medical Journal.

[3]  P. Kollman,et al.  Binding of a diverse set of ligands to avidin and streptavidin: an accurate quantitative prediction of their relative affinities by a combination of molecular mechanics and continuum solvent models. , 2000, Journal of medicinal chemistry.

[4]  D. Case,et al.  Insights into protein-protein binding by binding free energy calculation and free energy decomposition for the Ras-Raf and Ras-RalGDS complexes. , 2003, Journal of molecular biology.

[5]  Tingjun Hou,et al.  Assessing the Performance of the MM/PBSA and MM/GBSA Methods. 1. The Accuracy of Binding Free Energy Calculations Based on Molecular Dynamics Simulations , 2011, J. Chem. Inf. Model..

[6]  F. Winkler,et al.  Crystal structure of human dihydrofolate reductase complexed with folate. , 1988, European journal of biochemistry.

[7]  V. Cody,et al.  Methotrexate-resistant variants of human dihydrofolate reductase. Effects of Phe31 substitutions. , 1994, The Journal of biological chemistry.

[8]  D. Case,et al.  Exploring protein native states and large‐scale conformational changes with a modified generalized born model , 2004, Proteins.

[9]  J. Gready,et al.  QM/MM and SCRF studies of the ionization state of 8-methylpterin substrate bound to dihydrofolate reductase: existence of a low-barrier hydrogen bond. , 2000, Journal of molecular graphics & modelling.

[10]  S. Benkovic.  On the mechanism of action of folate- and biopterin-requiring enzymes. , 1980, Annual review of biochemistry.

[11]  W. Beard,et al.  Role of the conserved active site residue tryptophan-24 of human dihydrofolate reductase as revealed by mutagenesis. , 1991, Biochemistry.

[12]  P A Kollman,et al.  Free energy calculations on dimer stability of the HIV protease using molecular dynamics and a continuum solvent model. , 2000, Journal of molecular biology.

[13]  G. Scuseria,et al.  Gaussian 03, Revision E.01. , 2007 .

[14]  Jörg Weiser,et al.  Approximate atomic surfaces from linear combinations of pairwise overlaps (LCPO) , 1999, J. Comput. Chem..

[15]  J. Bertino,et al.  Cancer research: from folate antagonism to molecular targets. , 2009, Best practice & research. Clinical haematology.

[16]  D. Case,et al.  Characterization of domain-peptide interaction interface: a case study on the amphiphysin-1 SH3 domain. , 2008, Journal of molecular biology.

[17]  Amy C Anderson,et al.  Targeting DHFR in parasitic protozoa. , 2005, Drug discovery today.

[18]  P. Kollman,et al.  A well-behaved electrostatic potential-based method using charge restraints for deriving atomic char , 1993 .

[19]  Fernando D. Suvire,et al.  Molecular Modeling Study of Dihydrofolate Reductase Inhibitors. Molecular Dynamics Simulations, Quantum Mechanical Calculations, and Experimental Corroboration , 2013, J. Chem. Inf. Model..

[20]  J. Kraut,et al.  Loop and subdomain movements in the mechanism of Escherichia coli dihydrofolate reductase: crystallographic evidence. , 1997, Biochemistry.

[21]  Joelle N Pelletier,et al.  Multiple Conformers in Active Site of Human Dihydrofolate Reductase F31R/Q35E Double Mutant Suggest Structural Basis for Methotrexate Resistance* , 2009, The Journal of Biological Chemistry.

[22]  N. Day,et al.  Computational analysis of binding between malarial dihydrofolate reductases and anti-folates , 2010, Malaria Journal.

[23]  Paul J Shrimpton,et al.  Pivotal role of Gly 121 in dihydrofolate reductase from Escherichia coli: the altered structure of a mutant enzyme may form the basis of its diminished catalytic performance. , 2004, Biochemistry.

[24]  P. Stover,et al.  Identification of a de novo thymidylate biosynthesis pathway in mammalian mitochondria , 2011, Proceedings of the National Academy of Sciences.

[25]  R. Pictet,et al.  Site-directed mutagenesis of mouse dihydrofolate reductase. Mutants with increased resistance to methotrexate and trimethoprim. , 1988, The Journal of biological chemistry.

[26]  J. Kraut,et al.  Crystal structures of recombinant human dihydrofolate reductase complexed with folate and 5-deazafolate. , 1990, Biochemistry.

[27]  P. Kollman,et al.  Automatic atom type and bond type perception in molecular mechanical calculations. , 2006, Journal of molecular graphics & modelling.

[28]  Giulio Rastelli,et al.  Fast and accurate predictions of binding free energies using MM‐PBSA and MM‐GBSA , 2009, J. Comput. Chem..

[29]  B. Roth,et al.  2,4-Diamino-5-benzylpyrimidines and analogues as antibacterial agents. 5. 3',5'-Dimethoxy-4'-substituted-benzyl analogues of trimethoprim. , 1981, Journal of medicinal chemistry.

[30]  Methotrexate-resistant Variants of Human Dihydrofolate Reductase with Substitutions of Leucine 22 , 1995, The Journal of Biological Chemistry.

[31]  Holger Gohlke,et al.  Converging free energy estimates: MM‐PB(GB)SA studies on the protein–protein complex Ras–Raf , 2004, J. Comput. Chem..

[32]  J. Bertino,et al.  Design and rationale for novel antifolates. , 1987, NCI monographs : a publication of the National Cancer Institute.

[33]  N. Tawari,et al.  Design, synthesis, biological evaluation and computational investigation of novel inhibitors of dihydrofolate reductase of opportunistic pathogens. , 2010, Bioorganic & medicinal chemistry.

[34]  Peter L. Cummins,et al.  Molecular dynamics/free energy perturbation study on the relative affinities of the binding of reduced and oxidized NADP to dihydrofolate reductase , 1991 .

[35]  J. Gready,et al.  Molecular dynamics simulations of the docking of substituted N5-deazapterins to dihydrofolate reductase. , 1997, Protein engineering.

[36]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[37]  Wei Zhang,et al.  A point‐charge force field for molecular mechanics simulations of proteins based on condensed‐phase quantum mechanical calculations , 2003, J. Comput. Chem..

[38]  T. Darden,et al.  A smooth particle mesh Ewald method , 1995 .

[39]  R. Schilsky,et al.  Antifolates: the next generation. , 1992, Seminars in oncology.

[40]  Jiali Gao,et al.  Connecting protein conformational dynamics with catalytic function as illustrated in dihydrofolate reductase. , 2013, Biochemistry.

[41]  Carlos A M Fraga,et al.  Molecular Modeling Studies of Yersinia pestis Dihydrofolate Reductase , 2011, Journal of biomolecular structure & dynamics.

[42]  W. L. Jorgensen,et al.  Comparison of simple potential functions for simulating liquid water , 1983 .

[43]  Xiaojie Xu,et al.  Recent Advances in Free Energy Calculations with a Combination of Molecular Mechanics and Continuum Models , 2006 .

[44]  Peter E Wright,et al.  Structure, dynamics, and catalytic function of dihydrofolate reductase. , 2004, Annual review of biophysics and biomolecular structure.

[45]  Holger Gohlke,et al.  The Amber biomolecular simulation programs , 2005, J. Comput. Chem..

[46]  P. Kollman,et al.  Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. , 2000, Accounts of chemical research.

[47]  Junmei Wang,et al.  Development and testing of a general amber force field , 2004, J. Comput. Chem..

[48]  A. Parle‐McDermott,et al.  The former annotated human pseudogene dihydrofolate reductase-like 1 (DHFRL1) is expressed and functional , 2011, Proceedings of the National Academy of Sciences.

[49]  Chaok Seok,et al.  Cooperativity and specificity of Cys2His2 zinc finger protein-DNA interactions: a molecular dynamics simulation study. , 2010, The journal of physical chemistry. B.

[50]  F. Ruddle,et al.  Human dihydrofolate reductase gene is located in chromosome 5 and is unlinked to the related pseudogenes. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[51]  G. Ciccotti,et al.  Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes , 1977 .